Multinuclear 1H/13C/15N chemical shift assignment of therapeutic octreotide acetate performed at natural abundance

被引:1
作者
Menke, Alexander J. [1 ,3 ]
Chen, Fu [2 ]
Chen, Kang [1 ]
机构
[1] US FDA, Div Complex Drug Anal, Off Testing & Res, Off Pharmaceut Qual,Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA
[2] Univ Maryland, Dept Chem & Biochem, College Pk, MD USA
[3] Texas Christian Univ, Dept Chem & Biochem, Ft Worth, TX USA
基金
美国国家科学基金会;
关键词
C-13/N-15; CP-MAS; HMBC; HSQC-TOCSY; NMR; solid state; MHZ NMR-SPECTRA; CONFORMATIONAL-ANALYSIS; SOMATOSTATIN ANALOG; SMS; 201-995; IN-VITRO; C-13; H-1; SPECTROSCOPY; SMS-201-995; GLUCAGONOMA;
D O I
10.1002/mrc.5436
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Octreotide acetate, the active pharmaceutical ingredient in the long-acting release (LAR) drug product Sandostatin((R)), is a cyclic octapeptide that mimics the naturally occurring somatostatin peptide hormone. Modern NMR can be a robust analytical method to identify and quantify octreotide molecules. Previous H-1 chemical shift assignments were mostly performed in organic solvents, and no assignments for heteronuclear C-13, N-15, and aromatic H-1 nuclei are available. Here, using state-of-the-art 1D and 2D homo- and heteronuclear NMR experiments, octreotide was fully assigned, including water exchangeable amide protons, in aqueous buffer except for (CO)-C-13 and (NH)-N-15 of F1, (NH)-N-15 of C2, and N-15 zeta H zeta of K5 that were not observed because of water exchange or conformational exchange. The solution NMR spectra were then directly compared with 1D H-1/C-13/N-15 solid-state NMR (SSNMR) spectra showing the potential applicability of C-13/N-15 SSNMR for octreotide drug product characterization.
引用
收藏
页码:486 / 496
页数:11
相关论文
共 33 条
[1]   C-13, H-1 spin-spin coupling. X-Norbornane: A reinvestigation of the karplus curve for (3)J(C-13, H-1) [J].
AYDIN, R ;
GUNTHER, H .
MAGNETIC RESONANCE IN CHEMISTRY, 1990, 28 (05) :448-457
[2]  
BAUER W, 1982, LIFE SCI, V31, P1133, DOI 10.1016/0024-3205(82)90087-X
[3]   15N chemical shift referencing in solid state NMR [J].
Bertani, Philippe ;
Raya, Jesus ;
Bechinger, Burkhard .
SOLID STATE NUCLEAR MAGNETIC RESONANCE, 2014, 61-62 :15-18
[4]   Determination of relative configuration in organic compounds by NMR spectroscopy and computational methods [J].
Bifulco, Giuseppe ;
Dambruoso, Paolo ;
Gomez-Paloma, Luigi ;
Riccio, Raffaele .
CHEMICAL REVIEWS, 2007, 107 (09) :3744-3779
[5]   Synthesis and in vitro evaluation of a rhenium-cyclized somatostatin derivative series [J].
Bigott-Hennkens, Heather M. ;
Junnotula, Sulochana ;
Ma, Lixin ;
Gallazzi, Fabio ;
Lewis, Michael R. ;
Jurisson, Silvia S. .
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (05) :1223-1230
[6]   Synthesis of a dicarba-analog of octreotide keeping the type II' β-turn of the pharmacophore in water solution [J].
Carotenuto, A ;
D'Addona, D ;
Rivalta, E ;
Chelli, M ;
Papini, AM ;
Rovero, P ;
Ginanneschi, C .
LETTERS IN ORGANIC CHEMISTRY, 2005, 2 (03) :274-279
[7]  
D.o.H.a.H. Services, 1988, HIGHLIGHTS PRESCRIBI
[8]   Novel sst5-selective somatostatin dicarba-analogues:: synthesis and conformation-affinity relationships [J].
D'Addona, Debora ;
Carotenuto, Alfonso ;
Novellino, Ettore ;
Piccand, Veronique ;
Reubi, Jean Claude ;
Di Cianni, Alessandra ;
Gori, Francesca ;
Papini, Anna Maria ;
Ginanneschi, Mauro .
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (03) :512-520
[9]   NMR studies reveal structural differences between the gallium and yttrium complexes of DOTA-D-Phe1-Tyr3-octreotide [J].
Deshmukh, MV ;
Voll, G ;
Kühlewein, A ;
Mäcke, H ;
Schmitt, J ;
Kessler, H ;
Gemmecker, G .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (05) :1506-1514
[10]   A bioactive somatostatin analog-without a type II′ β-turn:: Synthesis and conformational analysis in solution [J].
Jiang, SK ;
Gazal, S ;
Gelerman, G ;
Ziv, O ;
Karpov, O ;
Litman, P ;
Bracha, M ;
Afargan, M ;
Gilon, C ;
Goodman, M .
JOURNAL OF PEPTIDE SCIENCE, 2001, 7 (10) :521-U5